Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACING-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACING

Published:2017-01-02 Issue:1 Volume:18 Page:1-16
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Spire Bruno¹,Nait-Ighil Lella²,Pugliese Pascal³,Poizot-Martin Isabelle⁴,Jullien Vincent⁵,Marcelin Anne-Geneviève⁶,Billaud Eric⁷

Affiliation:

1. INSERM UMR912 Aix-Marseille University, Marseille, France

2. Medical Départment, MSD France, Paris, France

3. Department of Infectious Diseases, L’Archet Hospital, Nice, France

4. Immuno-Hematology Clinic, Ste Marguerite Hospital, Marseille, France

5. Clinic Pharmacology Department, Cochin Hospital, Paris, France

6. Department of Virology, Pitié-Salpétrière Hospital, Paris, France

7. Department of Infectious Diseases, Hotel Dieu Hospital, Nantes, France

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

https://www.tandfonline.com/doi/pdf/10.1080/15284336.2016.1251030

Reference29 articles.

1. Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

2. Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients

3. Impact on Health-Related Quality of Life of a Switch From Enfuvirtide to Raltegravir Among Multidrug-Resistant HIV-1–Infected Patients: A Randomized Open-Label Trial (EASIER-ANRS 138)

4. A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease

5. Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort;Expert Review of Anti-infective Therapy;2020-02-25

2. Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir;JAIDS Journal of Acquired Immune Deficiency Syndromes;2018-12-01

3. Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system;HIV Clinical Trials;2018-09-03

4. Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women;AIDS;2018-03-13

5. Quality of life of people living with HIV compared with that of the general population in Japan;Journal of Infection and Chemotherapy;2017-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3